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Introduction
Hepatitis C virus (HCV) is a major cause of acute and 
chronic human hepatitis. Approximately 3 % of the 
world population (180 million people worldwide) is 
infected with HCV 1). Cure rate has risen to 45-75 % by 
the current standard treatment with combination of 
pegylated interferon (Peg-INF) with ribavirin (RBV). 
Moreover, by the addition of anti-protease inhibitors to 
the standard treatments, 70-95 % of complete response 
is expected2-5). In spite of development of such successful 
anti-HCV therapies, many patients with HCV in the 
world cannot reach these advanced medical treatments, 
and are anticipated alternative treatments having easier 
access and requiring less economical burden. Folk 
medicines of various areas in the world are hopeful 
candidate for developing novel HCV drugs to meet such 
demands 6). We reported that anti-HCV protease activity 
of an extract of a tropical fruit in Peru peel and seeds. 
Furthermore, its tannic ingredients supposed to be the 
active principles 7). We, therefore, focus on crude drugs 
which are known rich in tannin for their HCV protease 
activity using the recombinant enzyme.
Materials and methods
Extract preparation from crude drug material.
 Powdered crude drugs (Table 1) were obtained from 
Mikuni Co Ltd. The crude drug powders were kept in a 
desiccator for 48 hours for drying. Ten or 5 g of each 
crude drug powder was suspended in a 100 ml 
methanol and subjected to ultrasonic wave irradiation 
for 30 min. The methanol suspension was kept still, and 
the resulted clear methanol phase was obtained. The 
suspension in fresh methanol / ultrasonic irradiation 
was repeated two more times. All the methanol phases 
were combined and filtered, and the methanol was 
removed by evaporation. The remaining residue was 
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Abstract
 Aiming at finding novel hepatits C virus (HCV) drugs having easier access and requiring less 
economical burden, we studied on crude drugs for anti HCV protease activity. Thirteen crude drugs 
which are known rich in tannins were selected, since we had found peel and seeds of a tropical fruit in 
Peru, Camu camu, and their tannic ingredients were effectively inhibited the recombinant HCV 
protease. Methanolic extracts of the crude drugs were tested for inhibitory activity on the enzyme 
reaction, and 6 of them at a concentration of 100 µg/ml inhibited the reaction more than 90 %. Five of 
these effective extracts contained as much as 800-1500 µgGAE/ml phenolics, but the extract of kaki 
calyx (KC) contained less than 400 µgGAE/ml. On the other hand, that of gambir (Ga), which contained 
more than 1300 µgGAE/ml phenolics, did not effectively inhibit the reaction. We now focus on the 
effective ingredients contained in the extract of KC.
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 The HPLC analysis was made on a Shimadzu liquid 
chromatography system (LC-10ADvp Pumping Unit, 
DGU-14AM degasser, SPD-10A UV–VIS ultraviolet 
detector, CTO-10ACcolumn oven, Chromatopac C-R8A 
data processor, and SLC-10A System Controller) 
equipped with a Mightysil RP-18 Aqua 250-4.6 (5 µm) 
(Kanto Kagaku). The column was eluted with 23 % 
acetonitrile in 0.05 % trifluoroacetic acid at 40 ℃ . The 
UV signal at 210 nm of the cleaved product and the 
substrate was detected. Inhibition (%) was calculated 
based on the HPLC area of the remaining substrate of 
a reaction (Rn), that of positive control (PC), the 
reaction carried out without extract, and the negative 
control (NC), the reaction without enzyme and extract, 
as the following:
Inhibition (%) = 100 x (Rn-PC)/(NC-PC)
Total phenolics determination
 The total phenolics was determined colorimetrically by 
the modified method of Folin-Ciocalteau 10). Samples (40 
µl) were mixed with 5-fold diluted Folin-Ciocalteau 
reagent (0.5 ml), 10 % sodium carbonate (0.5 ml) and 
water (1 ml), and were incubated for 2 hr at room 
temperature. Absorbance at 760 nm was measured. 
The total phenolic content of the samples was 
expressed as µg gallic acid equivalent (GAE). The 
assays were carried out in triplicate.
Result and discussion
 The term of “tannin” is based on historical use of 
polyphenolics from plants that has been used for 
weighed, and dissolved in DMSO to a concentration of 
100 mg/ml. The DMSO solution was diluted to 2.0 mg/
ml and 0.2 mg/ml.
Recombinant HCV protease (∆NS3) preparation.
 An expression plasmid containing the amino acid 
sequence of HCV polypeptide from 1027 to 1218 and a 
six histidine residues in series at N-terminal adjoining 
region to the HCV peptide in Escherichia coli JM109 
was expressed according to the method reported 
previously 8). The bacterial pellet was yielded by 
centrifugation and stored at -30 ℃ . The expressed 
recombinant peptide with His-tag was purified using 
Ni-NTA Quick Start Kit (QIAGEN), and the purity of 
the peptide was estimated more than 80 %.
Enzyme reaction
 The recombinant enzyme together with the HCV NS4 
peptide P41 hovering amino acid 1673-1692, which was 
found cooperative for the proteolytic reaction, were 
reacted with a synthetic peptide S-1 (DDIVPC / 
SMSYTWT) corresponding the cleavage site of HCV 
NS5A/5B 9). The standard enzyme reaction of ∆NS3 was 
performed as followed: ∆NS3 (0.74 µM) and P41 (0.43 
mM) were incubated in a buffer (Tris-HCl (pH 7.8), 30 
mM NaCl, 5 mM CaCl2, 10 mM DTT) at 37 ℃ , and the 
reaction was started by addition of S-1 (85 µM). The 
reaction was prolonged for 15 min, and stopped by 
heating at 95 ℃ for 1 min. The assays were carried out 
in triplicate.
HPLC analysis
Table 1 Crude drugs used and yield of extraction
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contained as much as 1300 µgGAE/ml, did not show 
inhibitory activity at the concentration of 100 µg/ml. 
On the contrary, KC, which contained phenolics less 
than 400 µgGAE/ml, showed relatively high inhibitory 
activity of approximately 100 % and 30 % at the 
concentrations of 100 µg/ml and 10 µg/ml, respectively. 
The resu l t suggests that some pheno l ics are 
contributed to inhibition on enzyme, but all of phenolics 
a re no t neces sa r i l y i nh ib i t o ry . AS con ta i n s 
approximately 15 % of arecatannins, which is a class of 
condensed tannins containing epicatechins11). CF is rich 
in hydrolysable tannins, such as chebulagic acid, 
chebulinic acid, punicalagin12). On the other hand, Ga 
contains mainly smaller phenolics such as catechins and 
epicatechins, which were not very effective inhibitors 
for the enzyme reaction13). GH contains pentagalloyl 
glucose (PGG) 50 – 70 % 14), and PGG has IC50 8.5 µM 
for the HCV protease inhibition 13).  KC is reported to 
contain fatty acids, triterpenoids and flavonols15). The 
fruits and leaves of persimmon, on the other hands, are 
reported to have polyphenolics16). Ingredients of TP are 
not well known. Therefore, we are now concentrating 
on the KC, and their active ingredients for the HCV 
protease inhibition.
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Fig 1  Inhibition of enzyme reaction.
Fig 2  Phenolic content of crude drug extracts.
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要　旨
　C型肝炎ウイルス（HCV）感染者は、世界に１億人以上いるとされている。先進国では先端的な医薬品
の開発で、HCVを病原とする慢性及び急性C型肝炎の治癒率は飛躍的に高まった。一方、世界には経済的
に、また医療体制の問題から、それら先端医薬品を手に入れ難い地域も多い。我々は安価で、また手に入
れやすいC型肝炎治療薬を開発するために、各地の伝統薬物（生薬）に着目した。特にタンニンを多く含
んだ13生薬を選び、メタノールエキスを作成した。HCVの感染に必須であるHCVタンパク質分解酵素を、
大腸菌で生成し、この組み換え酵素に対する阻害効果をスクリーニングした。13のエキスのうち６のエキ
スの100 µg/mlに、90％以上のHCVタンパク質分解酵素阻害効果を認めた。ポリフェノール含量の高いエ
キス（800-1500 µgGAE/ml）が阻害効果も高い傾向であったが、阿仙薬エキスはポリフェノール含量が高
い（1300 µgGAE/ml以上）にも係らず、ほとんど阻害効果がなかった。一方柿蔕エキスは、ポリフェノー
ル含量は比較的低かったが（400 µgGAE/ml以下）、高い阻害活性が認められ、ポリフェノールの種類によっ
ても、阻害活性が異なることが示唆された。今後柿蔕の活性成分について、さらに詳しく研究する。
キーワード：HCVタンパク分解酵素，阻害剤，生薬，フェノール類
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